```
 _____  _  __  __        _                   
|  __ \(_)/ _|/ _| /\   | |                  
| |  | |_| |_| |_ /  \  | |__     ___  _ __  
| |  | | |  _|  _/ /\ \ | '_ \   / _ \| '_ \ 
| |__| | | | | |/ ____ \| |_) | | (_) | | | |
|_____/|_|_| |_/_/    \_\_.__/   \___/|_| |_|
                                             
                                             
 _   _                      _____                   
| \ | |                    / ____|                  
|  \| | ___ _   _ _ __ ___| (___  _ __   __ _ _ __  
| . ` |/ _ \ | | | '__/ _ \\___ \| '_ \ / _` | '_ \ 
| |\  |  __/ |_| | | | (_) |___) | | | | (_| | |_) |
|_| \_|\___|\__,_|_|  \___/_____/|_| |_|\__,_| .__/ 
                                             | |    
                                             |_|    

```

Antibodies are crucial immune proteins that defend the body by binding to specific antigens, such as viruses or bacteria. This interaction is largely driven by the **complementarity-determining regions (CDRs)** of the antibody. To streamline the design of novel CDRs for specific antigens, we offer a solution based on [**DiffAb**](https://openreview.net/forum?id=jSorGn2Tjg), a deep generative model that jointly models both the sequences and structures of CDRs. Leveraging diffusion probabilistic models and equivariant neural networks, DiffAb is the first deep learning-based method to generate antibodies explicitly targeting specific antigen structures. Capable of **sequence-structure co-design**, this model can produce competitive results in terms of binding affinity, evaluated by biophysical energy functions and other protein design metrics.

To read the entire blog post visit:


Want to try out the experiment yourself? Go to [neurosnap.ai](https://neurosnap.ai/) and try us out!
